Full-Time

Principal Scientific Advisor

Precision Motion

Confirmed live in the last 24 hours

Clairo

Clairo

5,001-10,000 employees

Clinical evidence generation for trials

No salary listed

Senior, Expert

Remote in Germany + 1 more

More locations: Remote in UK

Remote work is available, and candidates can be based in Leuven, Belgium, or other specified remote locations in Germany and the United Kingdom.

Category
Diagnostics & Laboratory Professionals
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • PhD in a relevant field (e.g., Neuroscience, Kinesiology, Biomedical Engineering) with focus in gait and balance disorders (Minimum 5-7+ years relevant experience)
  • Recognized expertise in movement analysis, particularly gait and balance impairments, with a strong understanding of digital clinical assessments and digital biomarker development
  • Expertise in use of Opals and Mobility Lab to measure balance and gait in patients with neurodegenerative disease required
  • Hands-on experience with Clario’s Opal device or similar wearable sensor technologies for gait and balance assessments
  • Experience in designing, implementing, and analyzing mobility-related outcomes in clinical trials using wearable technology
  • Strong presentation skills with experience engaging in pre-sales and post-sales scientific discussions
  • Demonstrated knowledge and understanding of business principles, including budgets, sales metrics/forecasting, and basic financial acumen
  • Excellent interpersonal and communication skills; Ability to understand and communicate with representatives from a range of disciplines within biopharmaceutical development
  • Ability to manage multiple priorities and projects, and balance workload and timelines; Able to work in a fast-paced and dynamic environment
Responsibilities
  • Oversee the scientific project handoff from sales to services, ensuring study objectives are clearly communicated
  • Provide input & documentation for implementation of data collection design strategy in conjunction with Client Services staff, including protocol review, test order and instructions, etc.
  • Lead the development and delivery of training for Client Services staff regarding movement endpoint design, scientific objectives of proposals, best practices, etc.
  • Supervise and manage scientific support for Client Services at selected post sales customer meetings
  • Lead the scientific input to product development decisions for Clario’s Precision Motion services
  • Develop, produce, and deliver presentations at professional forums, Clario’s webinar, conferences & meetings
  • Lead the preparation and review of publications, abstracts & white papers
  • Design and lead scientific projects which are designed to obtain marketing information
  • Stay current with scientific advancements, regulatory guidelines, and best practices impacting digital assessments in movement analysis
  • Lead the strategy for discussions with other industry scientists to facilitate Clario’s deliverables to clients
  • Direct the design of research studies and develop internal research pipeline and external outreach including webinars, abstracts, papers, white papers and related content
  • Engage with industry leaders, regulatory agencies, and scientific communities to shape Clario’s offerings in mobility-related clinical trials
  • Lead the scientific direction for clinical trial services related to movement analysis and digital mobility biomarkers within Clario
  • Serve as a subject matter expert (SME) in gait and balance disorders, providing guidance on study design, data collection, regulatory considerations, and best practices
  • Oversee and manage the process for reviewing study protocols from prospective customers & respond rapidly to meet client timelines
  • Direct the data collection design strategy for Clario’s Precision Motion solutions based on best practices, knowledge of literature, compliance, patient/site preference and applicable regulations
  • Lead the scientific support and content development for pre-sales engagements, capability and bid defense presentations
  • Develop and refine science-driven content for customer presentations, proposals industry discussions, and conferences
Desired Qualifications
  • Industry experience in clinical trial technology, digital health, or pharmaceutical research is highly desirable
  • Significant industry and market experience in conduct of clinical trials and drug development cycle
  • Industry recognized experience as a scientific expert and/or scientific team leader

Clario specializes in generating clinical evidence for medical research by combining scientific expertise with a wide range of endpoint technology. Their products support various types of clinical trials, including decentralized, hybrid, and site-based trials, allowing for flexibility in how studies are conducted. Clario stands out from competitors due to its extensive experience, having participated in nearly 19,000 clinical trials and achieved 870 regulatory approvals, which provides a high level of reliability in the data they produce. The company's goal is to empower partners in the healthcare industry to improve patient outcomes by providing comprehensive and trustworthy clinical evidence.

Company Size

5,001-10,000

Company Stage

Growth Equity (Venture Capital)

Total Funding

$29.9M

Headquarters

London, United Kingdom

Founded

1972

Simplify Jobs

Simplify's Take

What believers are saying

  • Clario's acquisition of NeuroRx enhances its neuroscience capabilities in multiple sclerosis imaging.
  • FDA clearance of SpiroSphere® with wireless ECG streamlines data collection in clinical trials.
  • Clario's $10 billion IPO filing indicates strong market interest and growth potential.

What critics are saying

  • Integration challenges may arise from Clario's acquisitions of NeuroRx and WCG's eCOA business.
  • AI partnership with PathAI could face algorithmic bias and data privacy concerns.
  • Wireless ECG device reliability and data security pose risks to trial outcomes and trust.

What makes Clairo unique

  • Clario offers a broad endpoint technology platform for diverse clinical trial models.
  • Trial Anywhere™ enables decentralized, hybrid, and site-based clinical trials with rich evidence.
  • Clario's 50 years of experience and 870 regulatory approvals enhance its credibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Company News

Fierce Biotech
Mar 18th, 2025
Clario continues acquisition spree with imaging specialist NeuroRx

NeuroRx founder and CEO Douglas Arnold, M.D., is also joining Clario as a senior scientific advisor, Clario announced in a March 17 release.

PE Hub
Mar 17th, 2025
PE-backed Clario picks up medical research firm NeuroRx

Clario, a Philadelphia-based provider of endpoint data solutions to the clinical trial industry, has acquired NeuroRx, a Montreal-based provider of imaging analysis on multiple sclerosis.

CityBiz
Mar 17th, 2025
Clario Acquires NeuroRx for Imaging Expertise

Clario, a leader in endpoint data solutions for clinical trials, has acquired NeuroRx, an imaging analysis expert in multiple sclerosis. This acquisition enhances Clario's neuroscience capabilities. NeuroRx's founder, Douglas Arnold, M.D., will join Clario as Senior Scientific Advisor. Clario also plans to acquire WCG’s eCOA business, further strengthening its neuroscience expertise.

PR Newswire
Mar 10th, 2025
Clario Enters Into Definitive Agreement To Acquire Wcg'S Ecoa Business

Acquisition of WCG's electronic clinical outcome assessments (eCOA) business will expand Clario's scientific expertise and offerings in neurosciencePHILADELPHIA, March 10, 2025 /PRNewswire/ -- Clario, a leading provider of endpoint data solutions to the clinical trial industry, today announced they have entered into a definitive agreement to acquire the eCOA business of WCG, a leader in providing solutions that measurably improve and accelerate clinical research. Electronic clinical outcomes assessments (eCOA), in addition to paper assessments, are used to evaluate the safety and efficacy of new drugs by measuring how a clinical trial participant feels or functions. WCG's eCOA operations offer robust, full-service clinical expertise and specialized functionality, particularly in neurology, psychiatry, neuropathic pain, and rare diseases

Clario
Oct 9th, 2024
Clario and PathAI Collaborate to Deliver Integrated Solution for GI Clinical Trials

PHILADELPHIA - October 10, 2024 - Clario, a leading provider of endpoint data solutions to the clinical trials industry, is excited to announce a strategic partnership with PathAI, a leader in AI-powered digital pathology solutions aimed at improving diagnostic accuracy and efficiency.